Wearable Devices for Type 2 Diabetes
(MPowerHub Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Day-to-day self-management by adults with type 2 diabetes, including glucose monitoring, taking medications, and healthy habits, is essential to avoid diabetes complications, yet, despite the rapidly expanding availability of wearable glucose and activity monitors, successful self-management remains challenging for many. This research aims to develop and test an approach to help adults use their personal diabetes information from wearable devices to achieve and sustain health diabetes self-management, which will reduce diabetes complications, and improve health and quality of life for people with type 2 diabetes.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it requires that you are currently prescribed at least one non-insulin diabetes medication.
Is the wearable device for Type 2 Diabetes, also known as MPowerHub, safe for humans?
The safety of wearable devices for diabetes management, like insulin pumps, can be affected by device malfunctions or user errors, which may lead to serious issues like high or low blood sugar. However, specific safety data for MPowerHub is not available, and more research is needed to ensure long-term safety in real-world use.12345
How is the treatment MPowerHub for type 2 diabetes different from other treatments?
What data supports the effectiveness of the treatment MPowerHub for Type 2 Diabetes?
Research shows that digital tools and wearable devices can help people with diabetes manage their condition better. For example, the Diabesdagboga app and Diani web portal improved blood sugar control in a patient with Type 1 diabetes, and the MyDiabetesMyWay platform in Scotland has positively impacted self-management for diabetes patients.811121314
Who Is on the Research Team?
Carissa Low, PhD
Principal Investigator
University of Pittsburgh
Ann-Marie Rosland, MD, MS
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for adults with type 2 diabetes who need help managing their condition. Participants should be interested in using wearable devices like glucose and activity monitors to track their health data.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use assigned study devices (MPowerHub, CGM, and/or activity tracker) for 4 months
Follow-up
Participants are monitored for changes in self-management behaviors and clinical outcomes
What Are the Treatments Tested in This Trial?
Interventions
- MPowerHub
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ann-Marie Rosland
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
The Pittsburgh Foundation
Collaborator